Products & Services, Research & Development
EMA's Pharmacovigilance Risk Assessment Committee (PRAC) assessed known risk of pneumonia with inhaled corticosteroids for chronic obstructive pulmonary disease
Report finds no differences in this risk between products.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you